Akebia Therapeutics (AKBA) Debt Ratio (2018 - 2025)
Historic Debt Ratio for Akebia Therapeutics (AKBA) over the last 8 years, with Q3 2025 value amounting to 0.13.
- Akebia Therapeutics' Debt Ratio fell 2934.48% to 0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13, marking a year-over-year decrease of 2934.48%. This contributed to the annual value of 0.18 for FY2024, which is 2219.53% up from last year.
- Akebia Therapeutics' Debt Ratio amounted to 0.13 in Q3 2025, which was down 2934.48% from 0.14 recorded in Q2 2025.
- In the past 5 years, Akebia Therapeutics' Debt Ratio ranged from a high of 0.19 in Q4 2022 and a low of 0.13 during Q3 2025
- For the 5-year period, Akebia Therapeutics' Debt Ratio averaged around 0.16, with its median value being 0.17 (2023).
- Its Debt Ratio has fluctuated over the past 5 years, first skyrocketed by 5911.44% in 2021, then plummeted by 2934.48% in 2025.
- Quarter analysis of 5 years shows Akebia Therapeutics' Debt Ratio stood at 0.18 in 2021, then rose by 0.71% to 0.19 in 2022, then fell by 22.68% to 0.14 in 2023, then increased by 22.2% to 0.18 in 2024, then decreased by 25.39% to 0.13 in 2025.
- Its Debt Ratio was 0.13 in Q3 2025, compared to 0.14 in Q2 2025 and 0.15 in Q1 2025.